Macrogenics Earnings Preview: Insider Trading and Hedge Fund Moves

Macrogenics is set to report its quarterly earnings, with analysts forecasting revenue of $33.5 million and an EPS of -$0.51. Insights into insider trading and hedge fund activity may impact stock sentiment.

Date: 03-03-2025

AI Rating: 5

Earnings Per Share (EPS): Analysts predict an EPS of -$0.51 for Macrogenics, which is a negative indicator as it shows the company is expected to incur losses. This can lead investors to be cautious about the company's future performance.

Revenue Growth: The expected revenue of $33,461,610 is a clear figure that reflects the company's anticipated performance this quarter. If achieved, this could meet or fall short of market expectations, affecting investor sentiment accordingly.

Insider Trading Activity: There has been one sale of 423 shares by an insider, which could raise potential red flags for investors about the management's outlook on the company's performance. Typically, insider selling is viewed negatively, suggesting that insiders may lack confidence in the company's future growth.

Hedge Fund Activity: The mixed activity among institutional investors could also contribute to stock price volatility. With 57 firms increasing their holdings in Macrogenics while 85 reduced theirs, this indicates uncertainty in the stock's future. Large withdrawals, like those from RA Capital Management and Hudson Bay Capital Management, highlight negative sentiment, while increases from firms like Wasatch Advisors may suggest some level of confidence among select investors.

Stocks: MGNX